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Primary Health Care Centre is known of having policy 
discrepancy with the supply of medicines. This can influence the 
adherence and costs incurred by patients. The study aimed to 
identify the influence for hypertensive patients at Primary Health 
Care Centre in Surabaya. This study was designed cross sectional 
and data collection was conducted by using ARMS questionnaires 
for the patient's adherence and interview for the cost of the 
treatment. The cost was calculated based on the frequency of 
real visits and monthly patient expenditures. Direct medical cost, 
direct non medical cost, and indirect cost were included based on 
patients’ perspective. Direct observations were performed to 
calculate the days of drug supplies. A total of 406 patients from 
50 Health Care Centre were included in the study. Days of drug 
supplies ranged from 3 to 30 days; total ARMS scores ranged 
from 12 to 33; and the total cost obtained ranged from IDR 
34,965 to IDR 239,528. The Spearman’s correlation test sought 
to obtain the significant influence of medication days’ supply on 
adherence with p value 0.0001 and r = -0.347. While medication 
days’ supply didn't show any significant influence on the cost. It 
will be significant if the patient met the visit schedule, that was p 
value 0.0001 and r=-0.247. It is recommended to prolong 
antihypertensive days’ supply in order to improve patients' 
adherence, as well as to reduce cost expensed by patients.  
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INTRODUCTION  
Hypertension is one of the leading 
causes of premature death worldwide. It is 
often referred as a silent killer because it does 
not show symptoms and many people do not 
realize it (WHO, 2011). In 2013, the prevalence 
of hypertension in Indonesia at age ≥ 18 years 
was 25.8% (Kemenkes RI, 2013). In Surabaya, 
there were 818,331 patients who visited primary 
heath care centre in 2015, and as many as 
16.78% suffered from hypertension (Dinkes 
Surabaya, 2015). 
Hypertension can be controlled by 
providing appropriate therapy both non-
pharmacological therapy and pharmacological 
therapy (Depkes, 2006). Pharmacological 
therapy using antihypertensives is a long-term 
therapy. Long-term therapy can lead to non-
adherence. Non-adherence in the treatment will 
have a negative impact, such as treatment 
failure, incidents of complications that 
aggravate health conditions, increased incidents 
of illness in hospitals, and rising health costs 
(Voorham, et al., 2003). Based on research 
conducted on 7,981 patients with hypertension 
under age of 65, it is indicated that low 
adherence rates may increase medical costs, 
drug costs and the risk for hospitalization so 
that the total costs incurred become larger 
(Sokol, et al., 2005). 
Primary health care centre as first-rate 
health facilities in the treatment of hypertension 
is known to have different policies in providing 
the amount of drugs to patients. The number 
of days of drug administration for hypertensive 
patients at some primary health care centres in 
Surabaya ranges from 5 to 10 days (Aldila, 
2015; Ananda, 2015; Riska, 2015). The short 
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number of medication days' supply cause the 
patients to have to visit the primary health care 
centre several times a month to get the 
medicine. This will affect the adherence and 
costs incurred patients. 
Research on adherence of hypertensive 
patients has been widely conducted (Hussar, 
2005; Aldila, 2015; Ananda, 2015; Riska, 2015) 
as well as research on adherence associated 
with the cost of treating hypertension (Sokol et 
al., 2005). Meanwhile, research on the number 
of days of drug administration associated with 
adherence and cost had never been done in 
Indonesia. There was a research in America 
that associated the number of days of drugs 
administration with adherence and cost (Taitel 
et al., 2012). However, in that research, the 
medication days' supply is given in a                  
long enough time that is between 30-90 days. 
Meanwhile in Indonesia the number of days of 
drug administration is between 5-10 days. 
Therefore, it is necessary to conduct           
research on the influence of medication days' 
supply on adherence and cost from the 
perspective of the patient so that later can be 
used as input to primary health care centre in 
order to give more effective and efficient 
service to society. 
 
MATERIAL AND METHODS 
This research was a survey that was 
designed cross sectional. Data was collected 
from February to May 2017. Compliance data 
were collected from ARMS questionnaire, cost 
data was obtained from interview result, and 
data on the number of days of drug 
administration was obtained from observation 
to respondents by counting the amount of drug 
received by the respondent. 
Sample in this research was a number of 
hypertension patients who get service at 
primary health care centre in Surabaya. The 
inclusion criteria of the sample included 1) 
patients who had been diagnosed with 
hypertension and took antihypertensive drugs 
for at least 1 month, 2) hypertensive patients 
who did outpatient treatment at primary health 
care in Surabaya, 3) hypertensive patients              
with age ≥ 18 years, 4) patients of hypertension 
receiving services from primary health care 
centre during the month of research, 5)  patient  
 
who   were   able  to   communicate  well,  and  
6) willing to be a research respondent.                      
The exclusion criteria of this study sample were 
patients who were not a permanent patient of 
the primary health care centre. Sampling was 
conducted using non random sampling method 
with accidental sampling technique. 
Adherence was measured by calculating 
the total ARM score, where the smaller total 
ARM score indicates that patient adherence is 
higher. The cost was measured based on 
patients perspective. The cost incurred by the 
patient included direct medical cost, direct non-
medical cost and indirect cost. Cost data was 
obtained by interview patients. Direct medical 
cost included cost incurred by patients to 
purchase antihypertensive drugs at pharmacies, 
laboratory examination costs, and doctor 
consultation fees outside primary health care 
centre over the past month. Direct non medical 
cost included transportation cost and 
administrative cost. Transportation cost was 
the cost of public transport issued by the 
patient or the cost of vehicle fuel per kilometer 
multiplied by the distance of the patient's house 
to the primary health care centre, pharmacy, or 
doctor including the parking fee in the last 
month. Administrative cost was cost incurred 
by patients who do not have Surabaya’s ID 
card or family card to get services in health 
centres. Indirect cost was cost caused by the 
loss of patient productivity due to not working 
for the control of the illness and getting 
medication at the health centre during the last 
month based on the patient's information 
during the interview. The effect of medication 
days' supply on adherence and cost was 
analyzed by Spearman correlation test. 
 
RESULT AND DISCUSSION 
From February to May 2017, 406 
respondents who met the inclusion criteria 
were found in 50 primary health care centres           
in Surabaya as presented in Demographic           
data of respondents (Table I). Based on               
the data (Table I), seen that 71.67% of 
respondents were women. This result was in 
accordance with the health profile data of 
Surabaya city where the number of            
female patients were higher than that of men 
(Dinkes Surabaya, 2015).  
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The prevalence of hypertension  in  women  is 
greater than that of men due to increased blood 
pressure  associated with estrogen hormone 
changes, overproduction of pituitary hormones, 
weight gain, oral contraceptive use, and 
unexplained non-hormonal influences 
(Chobanian et al., 2003). 
One of the factors that increase blood 
pressure is age, and it generally occurs in old 
age (Chobanian et al., 2003; Rajpura and Nayak, 
2014). The data showed that 58.62% of 
respondents were elderly patients (patients aged 
> 60 years). It was similar to a study in Nepal 
that showed the highest prevalence was 59.3% 
among participants above 60 years of age 
(Khanal et al., 2017). 
 The risk of hypertension can occur at 
the age above 18 years. The risk of 
hypertension in people with normal blood 
pressure will increase around the age of 55 
years (Saseen and MacLaughlin, 2008). The 
high risk of hypertension is in line with age due 
to structural changes in the large blood vessels, 
so the lumen becomes narrower and the blood 
vessel wall becomes stiff causing increased 
blood pressure (Kaplan, 2002). 
Data (Table I) showed that 93.60% of 
respondents have health insurance BPJS. This 
was in accordance with the vision of BPJS that 
no later than 2019 the entire population of 
Indonesia has become a BPJS participant (BPJS 
Kesehatan, 2013). There was a study that 
mention that most elderly use health insurance 
as a source of health funds (Yenny and 
Herwana, 2006). The existence of this health 
insurance can reduce the possibility of patients 
not seeking treatment and not redeeming the 
drug because of expensive prices. 
Table I. Demographic data 
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Employment data of respondents showed 
that as many as 47.54% of respondents were 
housewives (Table I). Most of respondents  
were housewives due to the prevalence of  
hypertension is greater in women than men 
(Hussain et al., 2016). In addition, the time 
required to seek treatment at primary  health  
care  centre  is long enough, according to some 
patients approximately 5h, and the opening 
hours of primary health care centre was same as 
the working hours of most patients. This causes 
the respondents who were still actively working 
tend to have less treatment in primary health 
care centre due to their inability to visit the 
primary health care centre. 
Adherence in this study was measured 
based on the total ARMS score. The lowest 
total ARMS score in this study was 12 and the 
highest was 33. Based on the data obtained, it  
showed that the number of days of drug 
administration for 15 days had the lowest 
average ARMS score of 13.3 (Table II). The 
low total ARMS score indicates better 
adherence (Kripalani et al., 2009). Disease 
factors such as hypertension make the patient 
tend to lack spirit with long-term therapy 
because it does not produce healing. This 
causes the patient to disobey. Long duration of 
therapy is also one of the factors of non-
adherence (Hussar, 2005). 
According to table II, it was seen that 
patients who received drugs with a long 
number of days were more adherent than 
patients who received drugs with a short 
number of days. The short number of 
medication days' supply causes the frequency of 
patients to have to return to the primary health 
care centre to get the medicine increased. Based 
on what some respondents said, they feel lazy 
to return to primary health care centre because 
they spend a long time to get the service so 
they prefer not to take the medicine or prefer 
to buy the medicine in the pharmacy. When the 
patient does not routinely return to the primary 
health care centre or choose not to take 
medication, the patient's blood pressure 
becomes uncontrolled and it would be difficult 
to reach the target of the appropriate blood 
pressure. The presence of such non-adherence 
may lead to deterioration of the patient's 
condition, the occurrence of complications, the 
unability of reaching the goal of the therapy, 
the increased unwanted reactions of drugs, 
death, and increased health costs (Hussar, 2005; 
Osterberg et al., 2005). 
In this study, the total cost of the patient 
during the treatment in the last 1 month was 
obtained by calculating direct medical costs, 
direct non-medical costs, and indirect costs. 
Direct medical costs were calculated by 
summing up the costs incurred by patients to 
buy drugs at pharmacies, laboratory 
examination fees, and medical examination fees 
outside primary health care centre for the past 
month. In general, the reason of the 
respondents to buy antihypertensive drugs in a 
pharmacy was because in the time required to 
visit the primary health care centre was longer 
patients. In addition, the distance to the 
pharmacy is closer to the respondent's 
residence than the primary health care centre, 
and with the cheap price, respondents could get 
Table II. Average total ARMS score 
 
Medication days’ supply n Average total ARMS score 
3 days 7 17.58±4.72 
4 days 2 16.00±5.29 
5 days 66 18.99±4.91 
6 days 31 17.37±5.60 
7 days 42 17.37±4.51 
8 days 4 15.50±4.39 
10 days 195 20.44±3.21 
14 days 16 14.69±4.06 
15 days 4 13.30±5.41 
30 days 39 13.64±2.65 
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all the medication needed. Generally, patients 
rarely pay for laboratory examination because 
the cost was borne by the insurance (BPJS).  
The direct non-medical costs were 
calculated from the administrative costs of the 
primary health care centre, the transportation 
costs of the patients to the primary health care 
centre, pharmacies, and doctors outside the 
primary  health  care centre for the past              month. 
Transportation costs were calculated based on 
the cost of public transport issued by the 
patient or the cost of vehicle fuel per kilometer 
multiplied by the distance of the patient's house 
to the primary health care centre, pharmacy, or 
doctor, including parking fees. 
Indirect costs were measured from the 
cost of reduced productivity at work. In this 
study, reduced productivity at work was 
calculated based on the question of how long  
the respondent complete the affairs at the 
primary health care centre then multiplied by 
hourly earnings. 
Table III shows the average details of 
the costs incurred by patients based on patient's 
real visits to the primary health care centre in 
one month. It can be seen that the indirect 
costs or cost of reducing the productivity of 
respondents when they visit the primary health 
care centre was the largest cost. 
In table III the results of the patient's 
cost calculations seem to fluctuate. Hence, it 
was necessary to calculate costs that must be 
spent if the patient obediently return to the 
primary health care centre in accordance with 
the schedule of drug administration (Table IV). 
This calculation was performed to compare the 
cost of the patient based on patient's real visit 
to the primary health care centre and the cost 
of the patients who obediently visit the primary 
health care centre in accordance with the 
schedule of drug administration. Based on the 
data in table IV, it can be seen that the cost to 
be paid by patients if they adhere to visit 
primary health care centre was much                
higher than the cost based on real visit 
according to the patient's acknowledgment. 
The data showed that the fewer days of drug 
administration, the more often patients have to 
go back to the primary health care centre, the 
greater the cost of the patient. This can be a 
factor that causes patients to rarely return to 
the primary health care centre in accordance 
with drug administration schedule. In              
(Table IV) there was no direct medical cost 
since the fee has been obtained free of charge 
from the primary health care centre. 
Analysis of the influence of number of 
days of antihypertensive drug administration on 
hypertensive patient adherence was done using 
Spearman correlation test. Based on the results 
of the analysis in the table V, the value of 
significant figure was 0.0001 (p <0.05). Thus, 
there was an influence of the medication days' 
supply on patient adherence. Meanwhile, the 
influence between the medication days' supply 
against adherence it seen by looking at the 
value of correlation coefficient, that was -0.347, 
which means the greater the number of days of 
drug administration, the lower total ARMS 
score. The low total ARMS score indicated high 
adherence. This was in accordance with the 
data obtained in table II, that the fewer 
medication days' supply, the higher the ARMS 
score the patient obtained. The higher the 
ARMS score obtained means the lower the 
patient's adherence (Kripalani, et al., 2009). 
Based on the results of analysis using Spearman 
correlation test (Table V) the value of significan 
figure for the cost of the patient based on the 
real visit according to the patient's 
acknowledgment was 0.755 (p>0.05) which 
means there was no influence of the medication 
days' supply on the cost incurred patient. This 
was probably due to the majority of patients 
did not return to the primary health care centre 
in accordance with the expected frequency of 
visits. For example, patients who received 
medication for 4 days, who should return to 
primary health care centre 7 times a month, 
based on the patient's acknowledgement, they 
visited primary health care centre only once a 
month so there was no difference of patient 
expense between patients who got drug for 4 
days and those who got drug for 30 days 
because both groups of patients were both 
visiting the primary health care centre only 
once a month. However, based on the analysis 
of the influence of the medication days' supply 
on the cost that should be spent by the patient 
if the patient was obedient to return to the 
primary health care centre in accordance with 
the number of days of drug administration, the 
value of significan figure was 0.0001 (p<005) 
with   correlation    coefficient    value    -0.247.  
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It means there was influence of medication 
days' supply on cost incurred by patients. The 
greater the medication days' supply, the lower 
the cost incurred by patients. 
 
Limitation of the study 
In this study cost data was obtained 
based on the patient's acknowledgement of            
the cost associated with hypertension during 
the last month, so it was probable what the 
patient recall was different from the actual cost. 
We suggest for further studies using patient 
diary method to give better precision of cost 
data.  
Different number of medication days’ 
supply consistently indicates the effect on 
adherence. In this research, the consistency test 
was done by comparing the result of correlation 














3 days 7 4,421.00 2,875.71 28,372.14 35,669.29±48,431.47 
4 days 2 0 0 25,000.00 25,000.00±35,355.34 
5 days 66 5,125.00 10,324.13 36,890.55    51,469.86±52,000.73 
6 days 31 4,011.00            4,656.03 34,615.68    43,282.68±58,738.89 
7 days 42 1,226.00      8,677.53 34,348.24   43,284.43±42,227.29 
8 days 4 0                20,766.75 10,250.00      31,016.75±31,460.62 
10 days 195 2,847.00   12,719.79 40,484.89 54,386.84±47,504.92 
14 days 16 62.00 11,049.79 49,969.06 59,699.44±81,122.21 
15 days 4 0 8,185.00 32,224.75 38,363.50±40,095.78 
30 days 39     1,795.00 7,716.69 17,146.79 27,473.68±28,598.27 
 
Table IV. The average cost that should be spent if patients regularly visited the primary health care 











3 days 7 8,899.14 187,961.90 196,861.04±144,482.8 
4 days 2 0 92,500.00 92,500.00±45,961.94 
5 days 66 20,500.51 122,691.60 143,192.11±127,520.2 
6 days 31 11,618.62 68,453.72 80,072.34±64,797.15 
7 days 42 10,711.12 84,720.00 95,431.12±58,809.41 
8 days 4 57,286.33 34,750.00 92,036.33±62,678.14 
10 days 195 13,085.67 70,106.82 83,192.49±78,280.01 
14 days 16 9,953.00 59,984.44 69,937.44±80,855.46 
15 days 4 6,138.25 32,224.75 38,363.01±40,096.34 
30 days 39 8,515.64 29,975.74 38,491.38±53,648.62 
 
Table V. Spearman correlation test result of the influence of medication days’ supply on adherence 
and cost in hypertensive patients (n = 406) 
 
 Correlation coefficient (r) pvalue 
Total ARMS score -0.347 0.0001 
Cost based on patients’ real visit in accordance with 
the patients’ acknowledgment 
0.015 0.755 
Cost that should be spent if patients regularly visited 
the primary health care centre on schedule 
-0.247 0.0001 
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test between medication days’ supply and cost 
according to the patient acknowledgement with 
cost simulation if the patient return to primary 
health care centre according to schedule. The 
results of this analysis indicate that the 
conclusion of correlation test results may 
change due to the frequency of patient visits 




Medication days’ supply influences 
adherence and costs incurred by hypertensive 
patients who seek treatment at primary health 
care centre. Patients who were given the drug 
for 30 days showed better adherence with a 
lower cost burden. 
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